Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.4 | Q2 | 71.0% | 1.170 | Q1 | 87.5% |
| 2024 | 3.4 | Q2 | 61.7% | 0.986 | Q1 | 83.9% |
| 2023 | 4.3 | Q1 | 76.2% | 1.313 | Q1 | 90.8% |
| 2022 | 10.0 | 94.4% | 1.495 | Q1 | 93.0% | |
| 2021 | — | 27.0% | 1.587 | Q1 | 93.7% | |
| 2020 | — | — | 0.684 | Q2 | 75.5% | |
| 2019 | — | — | 0.672 | Q2 | 75.9% | |
| 2018 | — | — | 0.760 | Q2 | 77.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1871-4021
ISSN
1878-0334
country
GBcoverage
2007-2026